Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M5,810Revenue (TTM) $M10,029Net Margin (%)-22.7Altman Z-Score0.2
Enterprise Value $M35,722EPS (TTM) $-6.6Operating Margin %-5.4Piotroski F-Score4
P/E(ttm)--Beneish M-Score-3.0Pre-tax Margin (%)-23.2Higher ROA y-yN
Price/Book1.410-y EBITDA Growth Rate %18.9Quick Ratio1.1Cash flow > EarningsY
Price/Sales0.65-y EBITDA Growth Rate %87.0Current Ratio1.5Lower Leverage y-yY
Price/Free Cash Flow3.2y-y EBITDA Growth Rate %-28.5ROA % (ttm)-4.7Higher Current Ratio y-yN
Dividend Yield %--PEG--ROE % (ttm)-41.5Less Shares Outstanding y-yY
Payout Ratio %--Shares Outstanding M348ROIC % (ttm)-1.1Gross Margin Increase y-yN

Gurus Latest Trades with VRX

Number of guru portfolios checked: 68.
Ticker Guru Date Action
Impact Price Range
(Average)*
Current Price Change from Average Comment Current Shares

VRX is held by these investors:



VRX: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
Ross Thomas W. Sr.Director 2016-12-14Buy5,000$14.739.84view
Pershing Square Capital ManageDirector 2016-12-12Sell3,476,690$14.858.96view
KARABELAS ARGERIS NDirector 2016-08-11Buy4,000$24.65-34.36view
Ross Thomas W. Sr.Director 2016-06-13Buy4,000$24.4-33.69view
PAPA JOSEPH CCHAIRMAN & CEO 2016-06-10Buy202,000$24.48-33.91view
Pearson J. MichaelCEO 2015-11-05Sell1,297,399$78.48-79.38view
Farmer Ronald HaroldDirector 2015-10-21Buy1,500$181.6-91.09view
Farmer Ronald HaroldDirector 2015-08-26Buy500$220-92.65view
Farmer Ronald HaroldDirector 2015-08-21Buy1,000$224.97-92.81view
Rosiello Robert L.EVP, CFO 2015-07-31Buy7,875$254.28-93.64view

Press Releases about VRX :

Quarterly/Annual Reports about VRX:

News about VRX:

Articles On GuruFocus.com
This Guru Loves Valeant; Should You? Feb 20 2017 
Francis Chou Adds to Valeant, Trims Sears in 4th Quarter Feb 16 2017 
Bill Ackman Expands Chipotle Position, Cuts Zoetis Feb 15 2017 
John Paulson's Bargain Stock Jan 30 2017 
How to Diversify Without Selling Stocks You Already Own and Love Jan 29 2017 
Ackman, Berkowitz May Not Get Their Fannie Mae Payout So Fast Under Trump Jan 27 2017 
A Fond Farewell Jan 21 2017 
23 Questions With Adam Strauss of Appleseed Fund Dec 28 2016 
Biotech Stocks to Watch After Senate Drug Report Dec 27 2016 
Bill Ackman Reduces Valeant Stake to Benefit Clients Dec 14 2016 

More From Other Websites
Facing Criticism, Drug Makers Keep Lid On Price Increases Feb 26 2017
Drug Companies Keep Lid on Price Increases Feb 26 2017
Top Biopharma Movers of the Past Week Feb 25 2017
Sequoia Fund wins dismissal of lawsuit over huge Valeant stake Feb 24 2017
Valeant's Ugly Earnings History May Repeat Itself Feb 24 2017
The Demise Of The Erectile Dysfunction TV Ads Feb 24 2017
Former Valeant and Philidor executives plead not guilty in fraud scheme Feb 23 2017
Former Valeant and Philidor execs plead not guilty in fraud scheme Feb 23 2017
Did 50 Salespeople Leave Valeant? Wells Fargo Investigates Feb 23 2017
Obagi Medical Products Announces Collaboration With Suzan Obagi, M.D., And Nextcell Medical To... Feb 23 2017
Obagi Medical Products Announces Collaboration With Suzan Obagi, M.D., And Nextcell Medical To... Feb 23 2017
PRESS DIGEST- New York Times business news - Feb 23 Feb 23 2017
​Tiny Waltham biotech's market cap doubles after $103M Valeant licensing deal Feb 21 2017
Valeant Acquires Eyegate Licensing Rights Feb 21 2017
Tuesday’s Top Biopharma Movers Feb 21 2017
The Zacks Analyst Blog Highlights: Merck, Valeant Pharmaceuticals International, Allergan,... Feb 21 2017
EyeGate Pharma surges 15% on news of Valeant licensing agreement Feb 21 2017
EyeGate Pharma surges 15% on news of Valeant licensing agreement Feb 21 2017
Valeant Pharmaceuticals And EyeGate Enter Into Licensing Agreement For EGP-437 Combination Product... Feb 21 2017
Valeant Pharmaceuticals And EyeGate Enter Into Licensing Agreement For EGP-437 Combination Product... Feb 21 2017
This Guru Loves Valeant; Should You? Feb 20 2017
[$$] Unilever was a deal too far for Kraft Heinz Feb 20 2017
Jaguar Animal Health, Inc. (NAS:JAGX) Given Company Update by Aegis Capital Corp. Jan 10 2017
Valeant sells $2B in assets to begin paying down debt Jan 10 2017
Valeant to sell Dendreon unit to China's Sanpower for $820 million Jan 09 2017
Valeant Pharmaceuticals Announces Addition Of Richard U. DeSchutter To Its Board Of Directors Jan 04 2017
Senators urge action to block drastic drug price hikes Dec 21 2016
Takeda's talks to acquire Valeant's Salix stall - sources Nov 30 2016
Valeant shares sink as company warns of rocky year ahead Nov 08 2016
Valeant shares sink as company warns of rocky year ahead Nov 08 2016
Valeant Reports Third Quarter 2016 Financial Results Nov 08 2016
Valeant sued for botching marketing of female libido pill Nov 02 2016
Japan's Takeda shares halted on news of interest in Valeant assets Nov 01 2016
Valeant says in talks to sell Salix stomach-drug business Nov 01 2016
Valeant Pharmaceuticals Comments On Press Report Regarding Its Gastroenterology Business Unit Nov 01 2016
Valeant Pharmaceuticals Comments On Press Report Oct 31 2016
Valeant Announces Third Quarter Financial Results Date And Conference Call Details Oct 17 2016
Valeant Patient Access And Pricing Committee Comments On Recent Pricing Action Decisions Oct 14 2016
Valeant Comments On Discount And Rebate Program For Nitropress And Isuprel Sep 16 2016
Valeant And Progenics Announce The U.S. Commercial Launch Of FDA-Approved Relistor® Tablets Sep 06 2016
Valeant is sued over Philidor ties, alleged racketeering Aug 29 2016
Valeant is sued over Philidor ties, alleged racketeering Aug 29 2016
Valeant is sued over Philidor ties, alleged racketeering Aug 29 2016
Valeant hires Zoetis's Paul Herendeen as CFO Aug 22 2016
Valeant Pharmaceuticals Appoints Paul S. Herendeen As Executive Vice President, Finance And Chief... Aug 22 2016
Valeant expected to announce Herendeen as new CFO - WSJ Aug 21 2016
LPC: Valeant lenders agree to loan amendment to loosen covenants Aug 18 2016
Valeant Pharmaceuticals Receives Lender Consent For Credit Facility Amendment Aug 18 2016
US stocks surge to new records as oil shares rally Aug 11 2016
Valeant stock falls as report of criminal probe adds to woes Aug 11 2016
Valeant Pharmaceuticals Comments On SDNY Investigation Aug 10 2016
Valeant under criminal investigation over Philidor ties - WSJ Aug 10 2016
Valeant under criminal investigation - WSJ Aug 10 2016
Valeant under criminal investigation - WSJ Aug 10 2016
LPC: Valeant loans rise after CEO says company to seek debt amendment Aug 09 2016
Valeant Pharmaceuticals Reports Second Quarter 2016 Financial Results Aug 09 2016
Valeant Pharmaceuticals Announces Relaunch Of Generic Ofloxacin Otic Solution Aug 08 2016
Valeant Pharmaceuticals Announces Significant Support For Education And Research Regarding Wilson... Aug 08 2016
Valeant Pharmaceuticals Announces Licensing Agreement With Norgine B.V. For NER1006 In U.S. And... Aug 08 2016
Valeant Pharmaceuticals Announces Changes To Executive Management Team Aug 08 2016

Add Notes, Comments

If you want to ask a question or report a bug, please create a support ticket.
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)